drugset / Trial / NCT01709032
Combination Deferasirox and Deferiprone for Severe Iron Overload in Thalassemia
Phase 1/2
Completed
9 enrolled
Children's Hospital of Philadelphia
Ann & Robert H Lurie Children's Hospital of Chicago · collabThe Cooley's Anemia Foundation, · collab
NaSingle-groupOpen-labelTreatment
Summary
We hypothesize that the combination treatment with deferasirox and deferiprone will be well tolerated and will result in significant improvement in cardiac and liver iron levels.
Timeline
- Start
- 2012-09
- Primary completion
- 2015-08-01
- Completion
- 2017-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Deferasirox | Unknown | — | Oral |
| Subject | Deferiprone | Small molecule | — | Oral |